Shares of nine pharma companies dropped by 1.4% to 6.03% after reports suggested that prosecutors at the US Federal Reserve may bring charges of price collusion against a group of generic drugmakers before the end of the year. Glenmark Pharmaceuticals (down 5.24%), Aurobindo Pharma (down 2
12.04 PM Nov 4th
Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on October 27, 2016 noted and approved the resignation of Mr. Sanjay Kumar Chowdhary, Company Secretary & Compliance Officer with effect from October 31, 2016.
4.08 PM Oct 28th
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on October 27, 2016, to consider and approve the Companys Unaudited Financial Statements for Second Quarter/Half Year ended September 30, 2016 (Q2).Further, as per the "Code of Conduct
4.27 PM Oct 17th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.